Current and historical daily PE Ratio for IRMD (
iRadimed Corp
) from 2014 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. iRadimed stock (IRMD) PE ratio as of Jun 05 2024 is 30.42.
More Details
iRadimed Corp (IRMD) PE Ratio (TTM) Chart
iRadimed Corp (IRMD) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1243
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| iRadimed PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | 30.3 | 2024-04-02 | 30.3 |
| 2024-06-04 | 30.3 | 2024-04-01 | 30.4 |
| 2024-06-03 | 30.7 | 2024-03-28 | 31.2 |
| 2024-05-31 | 30.1 | 2024-03-27 | 31.9 |
| 2024-05-30 | 29.9 | 2024-03-26 | 31.3 |
| 2024-05-29 | 29.9 | 2024-03-25 | 31.6 |
| 2024-05-28 | 30.6 | 2024-03-22 | 31.8 |
| 2024-05-24 | 30.1 | 2024-03-21 | 32.7 |
| 2024-05-23 | 29.9 | 2024-03-20 | 32.9 |
| 2024-05-22 | 30.9 | 2024-03-19 | 32.8 |
| 2024-05-21 | 31.3 | 2024-03-18 | 32.6 |
| 2024-05-20 | 31.1 | 2024-03-15 | 32.5 |
| 2024-05-17 | 29.8 | 2024-03-14 | 32.0 |
| 2024-05-16 | 30.3 | 2024-03-13 | 33.1 |
| 2024-05-15 | 29.9 | 2024-03-12 | 32.3 |
| 2024-05-14 | 30.0 | 2024-03-11 | 31.8 |
| 2024-05-13 | 30.1 | 2024-03-08 | 32.4 |
| 2024-05-10 | 30.9 | 2024-03-07 | 32.5 |
| 2024-05-09 | 30.3 | 2024-03-06 | 32.1 |
| 2024-05-08 | 30.8 | 2024-03-05 | 31.4 |
| 2024-05-07 | 31.0 | 2024-03-04 | 30.9 |
| 2024-05-06 | 30.9 | 2024-03-01 | 31.0 |
| 2024-05-03 | 31.7 | 2024-02-29 | 30.9 |
| 2024-05-02 | 31.1 | 2024-02-28 | 30.3 |
| 2024-05-01 | 29.8 | 2024-02-27 | 31.3 |
| 2024-04-30 | 28.8 | 2024-02-26 | 31.0 |
| 2024-04-29 | 29.0 | 2024-02-23 | 31.2 |
| 2024-04-26 | 29.7 | 2024-02-22 | 30.8 |
| 2024-04-25 | 29.4 | 2024-02-21 | 31.9 |
| 2024-04-24 | 30.1 | 2024-02-20 | 33.0 |
| 2024-04-23 | 29.7 | 2024-02-16 | 33.4 |
| 2024-04-22 | 30.0 | 2024-02-15 | 34.4 |
| 2024-04-19 | 29.1 | 2024-02-14 | 33.6 |
| 2024-04-18 | 28.6 | 2024-02-13 | 33.1 |
| 2024-04-17 | 28.7 | 2024-02-12 | 33.5 |
| 2024-04-16 | 29.1 | 2024-02-09 | 31.9 |
| 2024-04-15 | 29.0 | 2024-02-08 | 34.2 |
| 2024-04-12 | 29.3 | 2024-02-07 | 34.2 |
| 2024-04-11 | 29.8 | 2024-02-06 | 33.6 |
| 2024-04-10 | 29.2 | 2024-02-05 | 33.1 |
| 2024-04-09 | 29.8 | 2024-02-02 | 32.8 |
| 2024-04-08 | 30.0 | 2024-02-01 | 31.5 |
| 2024-04-05 | 30.1 | 2024-01-31 | 30.4 |
| 2024-04-04 | 29.3 | 2024-01-30 | 32.0 |
| 2024-04-03 | 30.0 | 2024-01-29 | 31.8 |
iRadimed Corp (IRMD) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
iRadimed Corp
NAICS : 334510
SIC : 3841
ISIN : US46266A1097
Description
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers